Similar articles for PMID: 24809777

Year	Number of Results
1999	1
2005	1
2006	2
2007	2
2008	4
2009	8
2010	9
2011	21
2012	22
2013	34
2014	55
2015	25
2016	18
2017	18
2018	12
2019	19
2020	17
2021	34
2022	51
2023	16
2024	0

1

Clinicopathologic and prognostic significance of c-MYC copy number gain in lung adenocarcinomas.

Seo AN, Yang JM, Kim H, Jheon S, Kim K, Lee CT, Jin Y, Yun S, Chung JH, Paik JH. Seo AN, et al. Br J Cancer. 2014 May 27;110(11):2688-99. doi: 10.1038/bjc.2014.218. Epub 2014 May 8. Br J Cancer. 2014. PMID: 24809777 Free PMC article.

2

MET gene copy number gain is an independent poor prognostic marker in Korean stage I lung adenocarcinomas.

Jin Y, Sun PL, Kim H, Seo AN, Jheon S, Lee CT, Chung JH. Jin Y, et al. Ann Surg Oncol. 2014 Feb;21(2):621-8. doi: 10.1245/s10434-013-3355-1. Epub 2013 Nov 9. Ann Surg Oncol. 2014. PMID: 24212721

3

Identification of EGFR mutation, KRAS mutation, and ALK gene rearrangement in cytological specimens of primary and metastatic lung adenocarcinoma.

Cai G, Wong R, Chhieng D, Levy GH, Gettinger SN, Herbst RS, Puchalski JT, Homer RJ, Hui P. Cai G, et al. Cancer Cytopathol. 2013 Sep;121(9):500-7. doi: 10.1002/cncy.21288. Epub 2013 Mar 12. Cancer Cytopathol. 2013. PMID: 23495083 Free article.

4

Clinicopathologic characteristics of ALK rearrangements in primary lung adenocarcinoma with identified EGFR and KRAS status.

Wang J, Dong Y, Cai Y, Zhou L, Wu S, Liu G, Su D, Li X, Qin N, Nong J, Jia H, Zhang Q, Mu J, Zeng X, Zhang H, Zhang S, Zhang Z. Wang J, et al. J Cancer Res Clin Oncol. 2014 Mar;140(3):453-60. doi: 10.1007/s00432-014-1584-8. Epub 2014 Jan 18. J Cancer Res Clin Oncol. 2014. PMID: 24442099

5

Differences in the survival of patients with recurrent versus de novo metastatic KRAS-mutant and EGFR-mutant lung adenocarcinomas.

Yu HA, Sima CS, Hellmann MD, Naidoo J, Busby N, Rodriguez K, Riely GJ, Kris MG. Yu HA, et al. Cancer. 2015 Jun 15;121(12):2078-82. doi: 10.1002/cncr.29313. Epub 2015 Mar 17. Cancer. 2015. PMID: 25781862 Free PMC article.

6

Mutational Profile and New IASLC/ATS/ERS Classification Provide Additional Prognostic Information about Lung Adenocarcinoma: A Study of 125 Patients from Brazil.

de Melo AC, Karen de Sá V, Sternberg C, Olivieri ER, Werneck da Cunha I, Fabro AT, Carraro DM, de Barros e Silva MJ, Pimenta Inada HK, de Mello ES, Soares FA, Takagaki T, Ferreira CG, Capelozzi VL. de Melo AC, et al. Oncology. 2015;89(3):175-86. doi: 10.1159/000376552. Epub 2015 Apr 1. Oncology. 2015. PMID: 25833149

7

Association of KRAS and EGFR mutations with survival in patients with advanced lung adenocarcinomas.

Johnson ML, Sima CS, Chaft J, Paik PK, Pao W, Kris MG, Ladanyi M, Riely GJ. Johnson ML, et al. Cancer. 2013 Jan 15;119(2):356-62. doi: 10.1002/cncr.27730. Epub 2012 Jul 18. Cancer. 2013. PMID: 22810899 Free PMC article.

8

Anaplastic lymphoma kinase gene rearrangements in non-small cell lung cancer are associated with prolonged progression-free survival on pemetrexed.

Camidge DR, Kono SA, Lu X, Okuyama S, Barón AE, Oton AB, Davies AM, Varella-Garcia M, Franklin W, Doebele RC. Camidge DR, et al. J Thorac Oncol. 2011 Apr;6(4):774-80. doi: 10.1097/JTO.0b013e31820cf053. J Thorac Oncol. 2011. PMID: 21336183 Free PMC article.

9

Clinicopathologic features and outcomes of patients with lung adenocarcinomas harboring BRAF mutations in the Lung Cancer Mutation Consortium.

Villaruz LC, Socinski MA, Abberbock S, Berry LD, Johnson BE, Kwiatkowski DJ, Iafrate AJ, Varella-Garcia M, Franklin WA, Camidge DR, Sequist LV, Haura EB, Ladanyi M, Kurland BF, Kugler K, Minna JD, Bunn PA, Kris MG. Villaruz LC, et al. Cancer. 2015 Feb 1;121(3):448-56. doi: 10.1002/cncr.29042. Epub 2014 Oct 1. Cancer. 2015. PMID: 25273224 Free PMC article.

10

ALK, ROS1 and RET fusions in 1139 lung adenocarcinomas: a comprehensive study of common and fusion pattern-specific clinicopathologic, histologic and cytologic features.

Pan Y, Zhang Y, Li Y, Hu H, Wang L, Li H, Wang R, Ye T, Luo X, Zhang Y, Li B, Cai D, Shen L, Sun Y, Chen H. Pan Y, et al. Lung Cancer. 2014 May;84(2):121-6. doi: 10.1016/j.lungcan.2014.02.007. Epub 2014 Feb 19. Lung Cancer. 2014. PMID: 24629636

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

316 results

Results by year